What is the typical dosing schedule for ProQuad (measles, mumps, rubella, and varicella vaccine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ProQuad Dosing Schedule

ProQuad is administered as a 2-dose series, with the first dose given at 12-15 months of age and the second dose at 4-6 years of age. 1

Standard Dosing Schedule

First Dose Timing

  • Administer the first dose between 12-15 months of age as part of routine childhood immunization 1
  • The minimum age for ProQuad administration is 12 months 2, 1
  • ProQuad is only approved for children aged 12 months through 12 years 2, 1

Second Dose Timing

  • Give the second dose routinely at 4-6 years of age (before entering prekindergarten, kindergarten, or first grade) 1
  • This timing is strategically chosen because varicella incidence and outbreaks are higher among elementary school-aged children compared to preschool-aged children 1
  • For children aged ≥48 months (4 years), MMRV (ProQuad) is generally preferred over separate MMR and varicella injections 3

Minimum Intervals Between Doses

Children 12 Months Through 12 Years

  • The minimum interval between first and second doses is 3 months 1
  • If the second dose is inadvertently administered between 28 days and 3 months after the first dose, it does not need to be repeated 1

Accelerated Schedule Option

  • The second dose may be administered earlier than 4-6 years, provided the minimum 3-month interval is met 1
  • This flexibility allows for catch-up vaccination when needed 1

Important Clinical Considerations

Age-Specific Febrile Seizure Risk

  • For children aged 12-47 months receiving their first measles-containing vaccine dose, consider using separate MMR and varicella vaccines instead of MMRV due to increased febrile seizure risk 3, 4
  • MMRV carries approximately one additional febrile seizure per 2,300-2,600 doses compared to separate vaccines in children aged 12-23 months 4
  • Children aged 4-6 years who received MMRV had no increased risk for febrile seizures, making ProQuad the preferred option at this age 3

Contraindication for ProQuad

  • Personal or family history (sibling or parent) of seizures is a contraindication for ProQuad; use separate MMR and varicella vaccines instead 3, 4

Storage and Administration

  • ProQuad is lyophilized and must be stored frozen at an average temperature of -15°C or colder until reconstitution 2
  • After reconstitution, keep at room temperature for a maximum of 30 minutes 2
  • Each 0.5 mL dose contains a minimum of 3.99 log10 PFU of varicella virus, which is higher than the monovalent varicella vaccine 2

Clinical Efficacy of Two-Dose Schedule

  • Two doses provide 98% vaccine efficacy compared to 94% for a single dose 1
  • Recipients of 2 doses are 3.3-fold less likely to have breakthrough varicella compared to those who received only 1 dose 1
  • After two doses, >99% of children achieve protective antibody levels against varicella 1

References

Guideline

Varicella Vaccine Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vaccination Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

MMR Vaccine Schedule Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.